Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran
Cytomegalovirus (CMV) causes infection in immunocompromised, transplant reci-pients and those who received blood transfusion frequently. Risk factors for primary CMV infec-tion are blood transfusion (including clotting factors, etc), recipients of infected transplants, hemo-dialysis and the frequenc...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
| Series: | Saudi Journal of Kidney Diseases and Transplantation |
| Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2010;volume=21;issue=2;spage=363;epage=367;aulast=Sepehrvand |
| _version_ | 1818260007933706240 |
|---|---|
| author | Sepehrvand Nariman Khameneh Zakieh Eslamloo Hamid-Reza |
| author_facet | Sepehrvand Nariman Khameneh Zakieh Eslamloo Hamid-Reza |
| author_sort | Sepehrvand Nariman |
| collection | DOAJ |
| description | Cytomegalovirus (CMV) causes infection in immunocompromised, transplant reci-pients and those who received blood transfusion frequently. Risk factors for primary CMV infec-tion are blood transfusion (including clotting factors, etc), recipients of infected transplants, hemo-dialysis and the frequency of dialysis in a week. This study aimed at determining the prevalence of cytomegalovirus (CMV) antibodies in end-stage renal disease (ESRD) patients who undergo hemodialysis. A cross-sectional study of hemodialysis patients in Urmia, Iran was undertaken in 2007. Sera of 84 Hemodialysis patients were investigated for CMV-specific immunoglobulin G (IgG). Forty-four (52%)<i> </i>patients were males. 65 patients (77.4%)<i> </i>were anti-CMV IgG positive and 6 (7.1%) were anti-CMV IgM positive. There was no relationship between the antibody titer and dialysis duration, or frequency of HD in a week. In conclusion, we recommend that every patient who has undergone hemodialysis receive blood products free of CMV if CMV negative to reduce the incidence and prevalence of CMV among HD patients. |
| first_indexed | 2024-12-12T18:24:30Z |
| format | Article |
| id | doaj.art-9db3a84dc8954b2583e13f80e22a8820 |
| institution | Directory Open Access Journal |
| issn | 1319-2442 |
| language | English |
| last_indexed | 2024-12-12T18:24:30Z |
| publishDate | 2010-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Saudi Journal of Kidney Diseases and Transplantation |
| spelling | doaj.art-9db3a84dc8954b2583e13f80e22a88202022-12-22T00:16:03ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422010-01-01212363367Survey the seroprevalence of CMV among hemodialysis patients in Urmia, IranSepehrvand NarimanKhameneh ZakiehEslamloo Hamid-RezaCytomegalovirus (CMV) causes infection in immunocompromised, transplant reci-pients and those who received blood transfusion frequently. Risk factors for primary CMV infec-tion are blood transfusion (including clotting factors, etc), recipients of infected transplants, hemo-dialysis and the frequency of dialysis in a week. This study aimed at determining the prevalence of cytomegalovirus (CMV) antibodies in end-stage renal disease (ESRD) patients who undergo hemodialysis. A cross-sectional study of hemodialysis patients in Urmia, Iran was undertaken in 2007. Sera of 84 Hemodialysis patients were investigated for CMV-specific immunoglobulin G (IgG). Forty-four (52%)<i> </i>patients were males. 65 patients (77.4%)<i> </i>were anti-CMV IgG positive and 6 (7.1%) were anti-CMV IgM positive. There was no relationship between the antibody titer and dialysis duration, or frequency of HD in a week. In conclusion, we recommend that every patient who has undergone hemodialysis receive blood products free of CMV if CMV negative to reduce the incidence and prevalence of CMV among HD patients.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2010;volume=21;issue=2;spage=363;epage=367;aulast=Sepehrvand |
| spellingShingle | Sepehrvand Nariman Khameneh Zakieh Eslamloo Hamid-Reza Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran Saudi Journal of Kidney Diseases and Transplantation |
| title | Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran |
| title_full | Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran |
| title_fullStr | Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran |
| title_full_unstemmed | Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran |
| title_short | Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran |
| title_sort | survey the seroprevalence of cmv among hemodialysis patients in urmia iran |
| url | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2010;volume=21;issue=2;spage=363;epage=367;aulast=Sepehrvand |
| work_keys_str_mv | AT sepehrvandnariman surveytheseroprevalenceofcmvamonghemodialysispatientsinurmiairan AT khamenehzakieh surveytheseroprevalenceofcmvamonghemodialysispatientsinurmiairan AT eslamloohamidreza surveytheseroprevalenceofcmvamonghemodialysispatientsinurmiairan |